The recent advance in technology for mass spectrometry-based targeted protein
quantification has opened new avenues for a broad range of proteomic applications in …

An early diagnosis of Alzheimer's disease (AD) and other types of dementia-causing
disorders is vital in order to achieve effective treatments. Fortunately, in the recent years the …

There is an urgent need for novel biomarkers that can be used to improve the diagnosis,
predict the disease progression, improve our understanding of the pathology or serve as …

The decline of cognitive skills throughout healthy or pathological aging can be slowed down
by experiences which foster cognitive reserve (CR). Recently, some studies on Alzheimer's …

Neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease
(PD), are characterized by progressive loss of cognitive function, dementia, and problems …

The ability to image the whole brain through ever more subtle and specific
methods/contrasts has come to play a key role in understanding the basis of brain …

Biomarkers for neurodegenerative disorders are essential to facilitate disease diagnosis,
ideally at early stages, monitor disease progression, and assess response to existing and …

To standardize the use of cerebrospinal fluid (CSF) for biomarker research, a set of stability
studies have been performed on porcine samples to investigate the influence of common …

Neurological diseases affect millions of peopleochemistryorldwide and are continuously
increasing due to the globe's aging population. Such diseases affect the nervous system …

Human cerebrospinal fluid (CSF) is an important source for studying protein biomarkers of
age‐related neurodegenerative diseases. Before characterizing biomarkers unique to each …